Mars Bioimaging

New Zealand
Christchurch, Canterbury, New Zealand, 8041

Company profile

Mars Bioimaging company profile

Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2007-01-01, Year

Headquarters

Postal code
8041
Country code
NZ
Continent
Oceania

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$15.5M
Last funding
Series A / $15M / 2026-01-13
Last equity funding
Series A / $15M
Investors
2
Lead investors
2
Founders
2
Articles
4

Founders and investors

Founders

Mark FiggitPhil Butler

Lead investors

Pacific ChannelPowerhouse Ventures

Investors

Pacific ChannelPowerhouse Ventures